Ignite Creation Date:
2024-05-06 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05727904
Status:
RECRUITING
Last Update Posted:
2024-07-08
First Post:
2023-02-06
Brief Title:
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma
Sponsor:
Iovance Biotherapeutics Inc
Organization:
Iovance Biotherapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-30
Start Date Type:
ACTUAL
Primary Completion Date:
2028-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-06
First Submit QC Date:
February 6 2023
Study First Post Date:
2023-02-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-30
Last Update Post Date:
2024-07-08
Last Update Post Date Type:
ACTUAL